114 related articles for article (PubMed ID: 25450863)
1. Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation.
Zou J; Gan X; Zhou H; Chen X; Guo Y; Chen J; Yang X; Lei J
Mol Cell Endocrinol; 2015 Jan; 399():321-9. PubMed ID: 25450863
[TBL] [Abstract][Full Text] [Related]
2. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1.
Zhang L; Zou J; Chai E; Qi Y; Zhang Y
Eur J Pharmacol; 2014 Dec; 744():203-10. PubMed ID: 25281201
[TBL] [Abstract][Full Text] [Related]
4. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
[TBL] [Abstract][Full Text] [Related]
5. C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB.
Zou J; Li H; Chen X; Zeng S; Ye J; Zhou C; Liu M; Zhang L; Yu N; Gan X; Zhou H; Xian Z; Chen S; Liu P
Mol Cell Endocrinol; 2014 Jun; 390(1-2):18-25. PubMed ID: 24704266
[TBL] [Abstract][Full Text] [Related]
6. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
7. Early and transient sodium-hydrogen exchanger isoform 1 inhibition attenuates subsequent cardiac hypertrophy and heart failure following coronary artery ligation.
Kilić A; Huang CX; Rajapurohitam V; Madwed JB; Karmazyn M
J Pharmacol Exp Ther; 2014 Dec; 351(3):492-9. PubMed ID: 25216745
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
9. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
Kilić A; Javadov S; Karmazyn M
J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy.
Zuo X; Xie H; Dong D; Jiang N; Zhu H; Kang YJ
Cardiovasc Toxicol; 2010 Sep; 10(3):208-15. PubMed ID: 20582486
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC
Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640
[TBL] [Abstract][Full Text] [Related]
15. SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.
Zhao ZH; Luo J; Li HX; Wang SH; Li XM
Mol Cell Biochem; 2018 Jun; 443(1-2):47-56. PubMed ID: 29110214
[TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
17. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Si L; Xu J; Yi C; Xu X; Wang F; Gu W; Zhang Y; Wang X
Int J Mol Med; 2014 Aug; 34(2):499-506. PubMed ID: 24827470
[TBL] [Abstract][Full Text] [Related]
18. Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.
Pang T; Gan XT; Freeman DJ; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H545-53. PubMed ID: 19966059
[TBL] [Abstract][Full Text] [Related]
19. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
20. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
